tax from higher priced recent quarters would partly account for the lower OCF, so I wouldn't extrapolate that.
NPAT tends to be about ~70% of EBITDA. So run rate NPAT was probably 160mil which equates to a pe of 7, but this excludes any contribution from bengalla increase, malabar and NAC3, and also there is significant obvious value in the cash balance of 730mil as well as the franking credits.
Clearly the NSW coal royalty issue is the biggest impending headwind but at current prices, hopefully this has a limited effect otherwise the industry is f^%ked
- Forums
- ASX - By Stock
- NHC
- Ann: Quarterly Activities Report
Ann: Quarterly Activities Report, page-9
Featured News
Add NHC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.62 |
Change
-0.060(1.28%) |
Mkt cap ! $3.905B |
Open | High | Low | Value | Volume |
$4.67 | $4.68 | $4.58 | $8.593M | 1.857M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 13552 | $4.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.64 | 4938 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 13552 | 4.600 |
4 | 22320 | 4.590 |
4 | 5973 | 4.580 |
4 | 6561 | 4.570 |
4 | 10810 | 4.560 |
Price($) | Vol. | No. |
---|---|---|
4.640 | 4938 | 2 |
4.650 | 5990 | 2 |
4.660 | 583 | 1 |
4.670 | 584 | 1 |
4.740 | 1000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
NHC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online